This website uses cookies

Read our Privacy policy and Terms of use for more information.

This free edition of Profit Snack is supported by Salesforce for Small Business, which brings your email marketing, customer tracking, sales pipeline, and support tools all in one place so your team can spend less time duct-taping workflows together.

American hospitals were spending hundreds of billions of dollars a year on billing infrastructure that consistently failed them, generating mountains of denied claims, uncollected revenue, and manual rework while remaining nearly impossible to disrupt. Everyone knew the billing system was broken, and the companies trying to fix it kept failing.

📊 Snackable Stat: $968M

Raised in Waystar’s June 2024 IPO, marking one of the largest healthcare technology listings of that year.

Here’s what you’ll learn: 

  • Why the most defensible position in an entrenched market is often the one that works around incumbents instead of against them.

  • How to sell into organizations that are institutionally wired to say no.

  • How to structure an acquisition so integration is already producing results before the fiscal year closes.

A $350 Billion Band-Aid on a Broken Billing System

American hospitals quietly accepted for decades that billing was fundamentally broken. Healthcare spending reached $4.3 trillion in 2021, with roughly $350 billion consumed by administrative overhead alone: paperwork, eligibility checks, prior authorizations, claims submissions, and denial appeals that added no clinical value.

The problem started before a single claim was ever filed. Industry data shows that 60% of all denials originate from front-end errors, such as eligibility mismatches and missing authorizations, mistakes that were entirely preventable. Yet most hospitals had spent years and hundreds of millions deploying EHR platforms from Epic and Cerner that were clinical tools first and financial tools never. Billing departments stitched the rest together with aging clearinghouses, manual spreadsheets, and fragmented payer portals that barely held.

The result was predictable and expensive. Hospitals lost 3% to 5% of net revenue annually to leakage even after those EHR investments, a number that stings when the aggregate operating margin for U.S. hospitals runs at just 5.2%. The industry was spending more than $20 billion a year fighting denied claims, and payers knew it.

That last part is important. Commercial insurers and managed care payers had turned claim denials into a deliberate cash management strategy. The more complex the appeals process, the more revenue they recovered through administrative attrition. Providers with understaffed revenue cycle teams simply wrote off contested claims rather than fight them.

A 2026 report covering full-year 2025 data made the scale undeniable. Kodiak Solutions found that more than 2,300 hospitals lost over $48 billion in net revenue to final claim denials and uncollected patient responsibilities in a single year, up 25% from the prior year. Most CFOs understood the problem. Almost none of them were willing to risk a billing disruption trying to fix it.

If you're the only one running campaigns, managing contacts, and chasing follow-ups — you can't afford to waste time jumping between tools. 

Salesforce Starter Suite brings your email marketing, CRM, lead tracking, and customer communication into one place, with automation that handles the repetitive work for you. Less tool-switching. More time actually marketing.

Try it free for 30 days (no credit card required)

Build the Layer, Not the Replacement

In November 2017, Bain Capital engineered the merger of two leading healthcare payment software companies, Navicure and ZirMed, into a single combined entity. The thesis was simple: a unified platform covering the entire revenue cycle would be structurally more valuable than a collection of point solutions. The combined business was renamed Waystar in February 2018 and grew more than 10x over the next five years, from $60 million in revenue to more than $600 million by 2022. In 2019, EQT Partners and the Canada Pension Plan Investment Board acquired a majority stake, valuing the company at $2.7 billion and committing capital to accelerate product investment and acquisitions.

What Waystar built was a philosophy as much as a product. Hospitals were not going to rip out Epic or Cerner. They had spent years and hundreds of millions embedding those systems into clinical workflows, and no CFO was going to sign a contract that put billing operations at risk. Waystar stopped trying to replace those systems and built a cloud-native integration layer that sat alongside them instead. The platform connected with more than 500 EHR and practice management systems, ultimately processing over $2.4 trillion in gross claims annually for more than a million distinct providers, including 16 of the top 20 U.S. News Best Hospitals.

The AI layer, branded AltitudeAI, became the platform's competitive edge. Rather than replacing billing staff, it embedded across Waystar's five core modules to automate the most error-prone steps. On the front end, an intelligent scrubbing engine caught coding errors, missing modifiers, and eligibility mismatches before submission, driving approximately 99% clean-claim rates at first pass. On the back end, predictive models flagged high-risk claims before they reached payers, and when denials did land, generative AI drafted appeal packages in two hours instead of 38, a 90% reduction in time that freed the equivalent of 13 full-time employees at a typical mid-size health system.

The business model reinforced every inch of it. A roughly even split between subscription and volume-based revenue meant Waystar earned more as providers grew. Contracts renewed on two-to-three-year cycles with built-in price escalators, creating structural switching costs without coercive lock-in.

The New Infrastructure

On June 7, 2024, Waystar listed on the Nasdaq under the ticker WAY, selling 45 million shares at $21.50 each and raising $968 million, one of healthcare technology's largest IPOs of that year. With proceeds directed toward debt repayment and platform investment, Waystar entered the public market with a cleaner balance sheet and an accelerating growth profile that most healthcare IT companies couldn't match.

Full-year 2025 revenue reached $1.1 billion, up 17% year-over-year, with Q4 alone growing 24% to $304 million. Adjusted EBITDA margins hit 42% for the year, exceeding the company's long-term 40% target ahead of schedule, while net revenue retention reached 112%. By that point, roughly 40% of total revenue came from AI-embedded workflows, and 30% of new 2025 bookings were driven specifically by AI capability. The flywheel Waystar had designed was working: more claims flowing through the system meant more data training the models, better denial prevention, more revenue captured, and a platform that became harder to leave with every passing quarter.

The $1.25 billion acquisition of Iodine Software, completed October 1, 2025, pushed Waystar into the mid-revenue cycle, the stage where up to 60 million claims per year are denied due to documentation errors between care delivery and submission. With only 35% customer overlap, Iodine added more than 1,000 hospitals and expanded Waystar's addressable market by over 15%. Integration ran ahead of schedule, with over 90% of committed cost synergies expected to land in fiscal 2026.

Key takeaways to consider…

  1. Sell Alongside the Incumbent, Not Against It. You don’t have to be a disruptor to win in your industry. Waystar grew from $60 million to over $1 billion in revenue by building a cloud-native layer that connected to 500+ existing systems rather than trying to replace them. 

  2. When your buyer is paid to maintain the status quo, ROI is the only argument that works. Hospital CFOs buy on numbers they can defend to a board, not on vision. Waystar led every sale with documented outcomes because a finance executive with thin margins has no room for a contract that doesn't pay for itself.  

  3. The Most Defensible Market Position Is the Most Embedded. Waystar held an estimated 4% share of the hospital segment and 8% of the ambulatory market at IPO. Those are not dominant numbers by any conventional measure. What made the business hard to attack was depth, not breadth: multi-year contracts, price escalators, data moats, and integration into clinical workflows that made removal operationally painful. Market share matters less than switching cost when you're playing a long game.

This free edition is supported by

Ready to transform artificial intelligence from a buzzword into your personal revenue generator? Our groundbreaking guide "200+ AI-Powered Income Ideas" is your gateway to financial innovation in the digital age.

Inside you'll discover:

  • A curated collection of 200+ profitable opportunities spanning content creation, e-commerce, gaming, and emerging digital markets—each vetted for real-world potential

  • Step-by-step implementation guides designed for beginners, making AI accessible regardless of your technical background

  • Cutting-edge strategies aligned with current market trends, ensuring your ventures stay ahead of the curve

🍫 Power Numbers

$1.1 billion - Full-year 2025 revenue

42.5% - Adjusted EBITDA margin for FY2025

112% - Net revenue retention rate for FY2025

$15 billion - Claim denials prevented by AltitudeAI in under one year

$1.8 trillion - Annual gross claims volume processed on the platform

60% - share of US patient population healthcare payments touch the Waystar platform annually

🍭 More Sweet Reads

As sports teams become platforms for content, brand-building, and real estate control, valuations are climbing fast, especially in leagues just beginning to tap their full business potential.

Everyone has a story. Few take the time to tell it. Whether you’re a founder, speaker, coach, or creative, your voice deserves a wider reach. This guide gives you what you need to build authority that opens doors and leaves a legacy.

The era of hype-driven AI is ending; disciplined, data-governed revenue engines are taking its place. Revenue leaders in this report agree that more tools and more signals don’t equal more clarity. What matters is isolating the few buyer signals that actually indicate intent, then wiring them into workflows that guide strategy, personalization, and prioritization in real time.

While Western capital ignored Sub‑Saharan Africa, this 29 year old methodically acquired “toll booth” assets, port concessions and logistics platforms that controlled the flow of entire national economies. From Lomé to Douala, he stitched together a network spanning 47 countries and 21,000 employees, then crystallized his bet when global shipping giants paid billions to take the same assets everyone else once considered toxic.

Want to reach 1,200+ product and marketing leaders at companies with at least 30 employees? Partner with us or drop a line to [email protected] to discuss custom campaigns.

Was this shared with you?

Reply

Avatar

or to participate

Keep Reading